Very interesting items in this week's C&EN:
- Lisa Jarvis has a really worthwhile write-up of 2014's new FDA-approved drugs.
- Andrea Widener writes about indirect costs.
- Here's hoping that the President gets research funding for antibiotics -- seems worthwhile. (article by Britt Erickson)
- An obituary for Nobel laureate Yves Chauvin by Bethany Halford.
Speaking of offset costs, colleague and I were discussing recently: if a research group levies funds through some alternative means to grants (private funding, kickstarter, bake sale), are those funds also subject to the same or similar indirect costs?
ReplyDeleteSame discussion in the group here. The University probably won't allow you to have alternative funding source, or they will take 50% as indirect as usual.
ReplyDelete